<DOC>
	<DOCNO>NCT00986232</DOCNO>
	<brief_summary>A Study compare three different dos ProQuad concomitant administration M-M-R II PUVV ( Process Upgrade Varicella Vaccine ) vaccine .</brief_summary>
	<brief_title>ProQuad Dose Selection Study ( V221-011 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Measles</mesh_term>
	<mesh_term>Rubella</mesh_term>
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>In good health Negative clinical history measles , mumps , rubella , varicella , zoster Previous receipt measles , mumps , rubella and/or varicella vaccine either alone combination Any immune impairment deficiency Exposure measles , mumps , rubella , varicella , zoster 4 week prior vaccination Vaccination inactive vaccine past 14 day Vaccination live vaccine within past 30 day Immune globulin blood product administer past 3 month</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>23 Months</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>